Cargando…

Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein

BACKGROUND: Abnormal aggregation of brain α-synuclein is a central step in the pathogenesis of Parkinson’s disease (PD), thus, it is reliable to promote the clearance of α-synuclein to prevent and treat PD. Recent studies have revealed an essential role of glymphatic system and meningeal lymphatic v...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Wenyan, Pu, Tinglin, Feng, Weixi, Lu, Ming, Zheng, Ying, Du, Renhong, Xiao, Ming, Hu, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396507/
https://www.ncbi.nlm.nih.gov/pubmed/30867902
http://dx.doi.org/10.1186/s40035-019-0147-y
_version_ 1783399267352707072
author Zou, Wenyan
Pu, Tinglin
Feng, Weixi
Lu, Ming
Zheng, Ying
Du, Renhong
Xiao, Ming
Hu, Gang
author_facet Zou, Wenyan
Pu, Tinglin
Feng, Weixi
Lu, Ming
Zheng, Ying
Du, Renhong
Xiao, Ming
Hu, Gang
author_sort Zou, Wenyan
collection PubMed
description BACKGROUND: Abnormal aggregation of brain α-synuclein is a central step in the pathogenesis of Parkinson’s disease (PD), thus, it is reliable to promote the clearance of α-synuclein to prevent and treat PD. Recent studies have revealed an essential role of glymphatic system and meningeal lymphatic vessels in the clearance of brain macromolecules, however, their pathophysiological aspects remain elusive. METHOD: Meningeal lymphatic drainage of 18-week-old A53T mice was blocked via ligating the deep cervical lymph nodes. Six weeks later, glymphatic functions and PD-like phenotypes were systemically analyzed. RESULTS: Glymphatic influx of cerebrospinal fluid tracer was reduced in A53T mice, accompanied with perivascular aggregation of α-synuclein and impaired polarization of aquaporin 4 expression in substantia nigra. Cervical lymphatic ligation aggravated glymphatic dysfunction of A53T mice, causing more severe accumulation of α-synuclein, glial activation, inflammation, dopaminergic neuronal loss and motor deficits. CONCLUSION: The results suggest that brain lymphatic clearance dysfunction may be an aggravating factor in PD pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40035-019-0147-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6396507
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63965072019-03-13 Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein Zou, Wenyan Pu, Tinglin Feng, Weixi Lu, Ming Zheng, Ying Du, Renhong Xiao, Ming Hu, Gang Transl Neurodegener Research BACKGROUND: Abnormal aggregation of brain α-synuclein is a central step in the pathogenesis of Parkinson’s disease (PD), thus, it is reliable to promote the clearance of α-synuclein to prevent and treat PD. Recent studies have revealed an essential role of glymphatic system and meningeal lymphatic vessels in the clearance of brain macromolecules, however, their pathophysiological aspects remain elusive. METHOD: Meningeal lymphatic drainage of 18-week-old A53T mice was blocked via ligating the deep cervical lymph nodes. Six weeks later, glymphatic functions and PD-like phenotypes were systemically analyzed. RESULTS: Glymphatic influx of cerebrospinal fluid tracer was reduced in A53T mice, accompanied with perivascular aggregation of α-synuclein and impaired polarization of aquaporin 4 expression in substantia nigra. Cervical lymphatic ligation aggravated glymphatic dysfunction of A53T mice, causing more severe accumulation of α-synuclein, glial activation, inflammation, dopaminergic neuronal loss and motor deficits. CONCLUSION: The results suggest that brain lymphatic clearance dysfunction may be an aggravating factor in PD pathology. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40035-019-0147-y) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-01 /pmc/articles/PMC6396507/ /pubmed/30867902 http://dx.doi.org/10.1186/s40035-019-0147-y Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zou, Wenyan
Pu, Tinglin
Feng, Weixi
Lu, Ming
Zheng, Ying
Du, Renhong
Xiao, Ming
Hu, Gang
Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
title Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
title_full Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
title_fullStr Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
title_full_unstemmed Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
title_short Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
title_sort blocking meningeal lymphatic drainage aggravates parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396507/
https://www.ncbi.nlm.nih.gov/pubmed/30867902
http://dx.doi.org/10.1186/s40035-019-0147-y
work_keys_str_mv AT zouwenyan blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein
AT putinglin blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein
AT fengweixi blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein
AT luming blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein
AT zhengying blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein
AT durenhong blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein
AT xiaoming blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein
AT hugang blockingmeningeallymphaticdrainageaggravatesparkinsonsdiseaselikepathologyinmiceoverexpressingmutatedasynuclein